Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya

Name: Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya
Published: 2014
License: Public Domain

University Hospital Muenster · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

relapsing remitting multiple sclerosis, rrms (relapsing remitting multiple sclerosis), cluster of differentiation 49d (cd49d), immune function, disease activity, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya

Related documents